IDEXX Laboratories, Inc.
DE ˙ XTRA ˙ US45168D1046
470,40 € ↓ -12,40 (-2,57%)
2026-06-03
AKTIENPREIS
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionWoodstock Corp
Latest Disclosed Ownership23,658 shares
Latest Disclosed Value $ 13,293,194
Woodstock Corp reports 2.11% decrease in ownership of IX1 / IDEXX Laboratories, Inc.

On April 8, 2026 - Woodstock Corp filed a 13F-HR form disclosing ownership of 23,658 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $11,545,104 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 24,168 shares of IDEXX Laboratories, Inc.. This represents a change in shares of -2.11% during the quarter. The current value of the position is $11,128,723 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 23,658 -510 -2.11 13,293 -18.70 1.1832
2026-01-14 2025-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 24,168 -55 -0.23 16,350 5.65 1.4031
2025-10-07 2025-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 24,223 -155 -0.64 15,476 18.36 1.3410
2025-07-09 2025-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 24,378 -159 -0.65 13,075 26.88 1.2017
2025-04-09 2025-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 24,537 -743 -2.94 10,304 -1.41 1.0179
2025-01-15 2024-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 25,280 -486 -1.89 10,452 -19.71 1.0069
2024-10-11 2024-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 25,766 -1,558 -5.70 13,017 -2.22 1.2526
2024-07-08 2024-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 27,324 50 0.18 13,312 -9.60 1.3537
2024-04-09 2024-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 27,274 302 1.12 14,726 -1.63 1.5244
2024-01-08 2023-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 26,972 32 0.12 14,971 27.08 1.7336
2023-10-10 2023-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 26,940 -179 -0.66 11,780 -13.50 1.4772
2023-07-07 2023-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 27,119 -998 -3.55 13,620 -3.14 1.6071
2023-04-06 2023-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 28,117 -12 -0.04 14,061 22.53 1.7932
2023-01-10 2022-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 28,129 -1,658 -5.57 11,476 18.24 1.5252
2022-10-11 2022-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 29,787 -593 -1.95 9,705 -8.92 1.4438
2022-07-11 2022-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 30,380 250 0.83 10,655 -35.36 1.4789
2022-04-07 2022-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 30,130 -3,963 -11.62 16,483 -26.58 1.9302
2022-01-07 2021-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 34,093 -788 -2.26 22,449 3.49 2.3506
2021-10-05 2021-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 34,881 -495 -1.40 21,692 -2.91 2.5297
2021-07-06 2021-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 35,376 -1,028 -2.82 22,342 25.43 2.6289
2021-04-05 2021-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 36,404 -3,023 -7.67 17,813 -9.62 2.2646
2021-01-06 2020-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 39,427 -334 -0.84 19,708 26.09 2.6379
2020-10-02 2020-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 39,761 -1,825 -4.39 15,630 13.84 2.5241
2020-07-07 2020-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 41,586 -234 -0.56 13,730 35.54 2.3405
2020-04-03 2020-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 41,820 -335 -0.79 10,130 -7.98 2.0642
2020-01-13 2019-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 42,155 -160 -0.38 11,008 -4.34 1.7929
2019-10-02 2019-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 42,315 -170 -0.40 11,507 -1.62 2.0048
2019-07-03 2019-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 42,485 -3,100 -6.80 11,697 14.76 2.0421
2019-04-05 2019-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 45,585 -165 -0.36 10,193 19.78 1.8262
2019-01-08 2018-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 45,750 -728 -1.57 8,510 -26.66 1.7077
2018-10-03 2018-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 46,478 -1,505 -3.14 11,604 10.97 1.9612
2018-07-23 2018-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 47,983 -50 -0.10 10,457 13.75 1.9250
2018-04-19 2018-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 48,033 -1,475 -2.98 9,193 18.74 1.7383
2018-01-24 2017-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 49,508 -522 -1.04 7,742 -0.48 1.4278
2017-10-06 2017-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 50,030 -380 -0.75 7,779 -4.40 1.4829
2017-07-13 2017-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 50,410 -1,650 -3.17 8,137 1.09 1.5949
2017-04-05 2017-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 52,060 -7,300 -12.30 8,049 15.63 1.6223
2017-01-05 2016-12-31 13F Idexx Laboratories COMMON STOCK 45168D104 59,360 -1,115 -1.84 6,961 2.11 1.4111
2016-10-06 2016-09-30 13F Idexx Laboratories COMMON STOCK 45168D104 60,475 -2,095 -3.35 6,817 17.33 1.3949
2016-08-03 2016-06-30 13F Idexx Laboratories COMMON STOCK 45168D104 62,570 -100 -0.16 5,810 18.38 1.1992
2016-05-10 2016-03-31 13F Idexx Laboratories COMMON STOCK 45168D104 62,670 -3,400 -5.15 4,908 1.87 1.0325
2016-01-11 2015-12-31 13F IDEXX LABS COMMON STOCK 45168D104 66,070 -1,100 -1.64 4,818 -3.39 1.0593
2015-10-16 2015-09-30 13F IDEXX LABS COMMON STOCK 45168D104 67,170 -1,250 -1.83 4,987 13.65 1.1353
2015-07-07 2015-06-30 13F IDEXX LABS COMMON STOCK 45168D104 68,420 34,710 102.97 4,388 -15.75 0.8269
2015-04-09 2015-03-31 13F IDEXX LABS COMMON STOCK 45168D104 33,710 470 1.41 5,208 5.68 0.9664
2015-02-13 2014-12-31 13F IDEXX LABS COMMON STOCK 45168D104 33,240 0 0.00 4,928 25.81 0.9154
2014-10-06 2014-09-30 13F IDEXX LABS COMMON STOCK 45168D104 33,240 -1,545 -4.44 3,917 -15.69 0.7536
2014-07-07 2014-06-30 13F IDEXX LABS COMMON STOCK 45168D104 34,785 -100 -0.29 4,646 9.70 0.8232
2014-04-07 2014-03-31 13F IDEXX LABS COMMON STOCK 45168D104 34,885 200 0.58 4,235 14.80 0.7877
2014-01-13 2013-12-31 13F IDEXX LABS COMMON STOCK 45168D104 34,685 -1,370 -3.80 3,689 2.67 0.6701
2013-10-07 2013-09-30 13F IDEXX LABS COMMON STOCK 45168D104 36,055 0 0.00 3,593 11.10 0.7117
2013-07-09 2013-06-30 13F IDEXX LABS COMMON STOCK 45168D104 36,055 36,055 3,234 0.6609
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.